Xencor Inc. Form 8-K Summary
Business Context and Reporting Period
Xencor Inc. (XNCR) filed this Current Report on Form 8-K on November 24, 2020, to disclose the entry into a material definitive agreement. The company is a biopharmaceutical firm headquartered in Monrovia, California.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a lease amendment.
Material Changes and Agreement Details
On November 24, 2020, Xencor entered into a Fifth Amendment to its Lease with 111 Lemon Investors LLC regarding its corporate headquarters and research space at 111 West Lemon Avenue, Monrovia, California. Key terms include:
- Effective Date: October 31, 2020.
- Term Extension: Extends the lease for the second floor of the premises for 62 months, ending December 31, 2025.
- Rent Obligation: Initial base monthly rent of approximately $55,289.
- Rent Escalation: Monthly base rent increases annually by approximately 3% of the then-current base rent.
- Extension Option: The company has the option to extend the lease for one additional five-year period subject to certain conditions.
- Clarifications: The amendment clarifies obligations regarding excess annual operating and tax expenses.
Guidance, Outlook, and Risks
The filing contains no financial guidance, management outlook, or discussion of risks beyond the contractual obligations of the lease amendment. The full text of the Amendment is referenced as an exhibit to the company's Annual Report on Form 10-K for the period ended December 31, 2020.
Investor Verification Checklist
- Verify the total committed lease liability through December 2025 based on the $55,289 monthly base rent and 3% annual escalation.
- Review the specific conditions required to exercise the five-year extension option.
- Examine the clarification on excess annual operating and tax expenses to understand potential variable cost increases.
- Confirm the full text of the Fifth Amendment in the subsequent Form 10-K filing.